1. Home
  2. KRRO vs GBAB Comparison

KRRO vs GBAB Comparison

Compare KRRO & GBAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRRO
  • GBAB
  • Stock Information
  • Founded
  • KRRO 2014
  • GBAB 2010
  • Country
  • KRRO United States
  • GBAB United States
  • Employees
  • KRRO N/A
  • GBAB N/A
  • Industry
  • KRRO Biotechnology: Pharmaceutical Preparations
  • GBAB Investment Managers
  • Sector
  • KRRO Health Care
  • GBAB Finance
  • Exchange
  • KRRO Nasdaq
  • GBAB Nasdaq
  • Market Cap
  • KRRO 358.3M
  • GBAB 417.0M
  • IPO Year
  • KRRO 2019
  • GBAB N/A
  • Fundamental
  • Price
  • KRRO $34.30
  • GBAB $15.49
  • Analyst Decision
  • KRRO Strong Buy
  • GBAB
  • Analyst Count
  • KRRO 8
  • GBAB 0
  • Target Price
  • KRRO $96.25
  • GBAB N/A
  • AVG Volume (30 Days)
  • KRRO 194.0K
  • GBAB 69.4K
  • Earning Date
  • KRRO 11-12-2025
  • GBAB 01-01-0001
  • Dividend Yield
  • KRRO N/A
  • GBAB 9.18%
  • EPS Growth
  • KRRO N/A
  • GBAB N/A
  • EPS
  • KRRO N/A
  • GBAB N/A
  • Revenue
  • KRRO $6,281,000.00
  • GBAB N/A
  • Revenue This Year
  • KRRO $116.91
  • GBAB N/A
  • Revenue Next Year
  • KRRO N/A
  • GBAB N/A
  • P/E Ratio
  • KRRO N/A
  • GBAB N/A
  • Revenue Growth
  • KRRO N/A
  • GBAB N/A
  • 52 Week Low
  • KRRO $10.29
  • GBAB $14.22
  • 52 Week High
  • KRRO $76.79
  • GBAB $17.44
  • Technical
  • Relative Strength Index (RSI)
  • KRRO 42.32
  • GBAB 45.17
  • Support Level
  • KRRO $31.17
  • GBAB $15.46
  • Resistance Level
  • KRRO $42.70
  • GBAB $15.63
  • Average True Range (ATR)
  • KRRO 3.80
  • GBAB 0.17
  • MACD
  • KRRO -1.37
  • GBAB -0.01
  • Stochastic Oscillator
  • KRRO 20.10
  • GBAB 19.98

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

About GBAB Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust of Beneficial Interest

Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust is a diversified closed-end management investment company. Its investment objective is to provide current income with a secondary objective of long-term capital appreciation. Its products include Mutual funds, Unit investment trusts, Closed-end funds, Rydex funds, Credit income fund and others.

Share on Social Networks: